Currently, it is unknown whether the upregulation of PD-L1 in the patient’s tumor referenced in this study is associated with the upregulation of MHC-I; however, we demonstrated increased levels of Her-2/neu-specific IFNγ production in the patient in a phase Ib trial [10]. This evidence concerns the gene CD274 and neoplasm.